Sunshine Biopharma Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 47

Employees

  • Stock Symbol
  • SBFM

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $2.68
  • (As of Wednesday Closing)

Sunshine Biopharma General Information

Description

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Contact Information

Formerly Known As
Mountain State Business Solutions,Inc, Mountain West Business Solutions,Inc
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1177 Avenue of the Americas
  • 5th Floor
  • New York, NY 10036
  • United States
+1 (332)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1177 Avenue of the Americas
  • 5th Floor
  • New York, NY 10036
  • United States
+1 (332)

Sunshine Biopharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sunshine Biopharma Stock Performance

As of 06-Nov-2024, Sunshine Biopharma’s stock price is $2.68. Its current market cap is $5.36M with 2M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.68 $2.86 $2.42 - $637.20 $5.36M 2M 187K -$127.90

Sunshine Biopharma Financials Summary

As of 30-Sep-2024, Sunshine Biopharma has a trailing 12-month revenue of $33M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV (7,024) (11,200) (26,101) 31,361
Revenue 32,959 24,093 4,346 228
EBITDA (4,465) (4,636) (26,965) (12,095)
Net Income (4,226) (4,506) (26,744) (12,436)
Total Assets 30,057 27,347 29,244 2,203
Total Debt 557 658 765 1,900
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sunshine Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sunshine Biopharma‘s full profile, request access.

Request a free trial

Sunshine Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of t
Drug Discovery
New York, NY
47 As of 2024

Carlsbad, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sunshine Biopharma Competitors (9)

One of Sunshine Biopharma’s 9 competitors is Ionis Pharmaceuticals, a Corporate Backed or Acquired company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ionis Pharmaceuticals Corporate Backed or Acquired Carlsbad, CA
Kintara Therapeutics Corporation San Diego, CA
Gilead Sciences Formerly VC-backed Foster City, CA
Amgen Formerly PE-Backed Thousand Oaks, CA
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 9 competitors. Get the full list »

Sunshine Biopharma Patents

Sunshine Biopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230234986-A1 Inhibitors of coronavirus protease Pending 22-May-2020
US-20150353573-A1 Gem-difluorinated c-glycoside compounds as anti-cancer agents Active 14-Jan-2013
US-10272065-B2 Gem-difluorinated c-glycoside compounds as anti-cancer agents Active 14-Jan-2013
EP-3530663-A1 Process for preparing gem-difluorinated c-glycoside compounds Active 14-Jan-2013
EP-3530663-B1 Process for preparing gem-difluorinated c-glycoside compounds Active 14-Jan-2013 A61K31/365
To view Sunshine Biopharma’s complete patent history, request access »

Sunshine Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sunshine Biopharma Acquisitions (2)

Sunshine Biopharma’s most recent deal was a Merger/Acquisition with Nora Pharma for . The deal was made on 20-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nora Pharma 20-Oct-2022 Merger/Acquisition Pharmaceuticals
Atlas Pharma 01-Jan-2018 Merger/Acquisition Laboratory Services (Healthcare)
To view Sunshine Biopharma’s complete acquisitions history, request access »

Sunshine Biopharma Subsidiaries (2)

Company Name Industry Location Founded
Nora Pharma Pharmaceuticals Varennes, Canada 2017
Atlas Pharma Laboratory Services (Healthcare) Montreal, Canada
To view Sunshine Biopharma’s complete subsidiaries history, request access »

Sunshine Biopharma FAQs

  • When was Sunshine Biopharma founded?

    Sunshine Biopharma was founded in 2006.

  • Where is Sunshine Biopharma headquartered?

    Sunshine Biopharma is headquartered in New York, NY.

  • What is the size of Sunshine Biopharma?

    Sunshine Biopharma has 47 total employees.

  • What industry is Sunshine Biopharma in?

    Sunshine Biopharma’s primary industry is Drug Discovery.

  • Is Sunshine Biopharma a private or public company?

    Sunshine Biopharma is a Public company.

  • What is Sunshine Biopharma’s stock symbol?

    The ticker symbol for Sunshine Biopharma is SBFM.

  • What is the current stock price of Sunshine Biopharma?

    As of 06-Nov-2024 the stock price of Sunshine Biopharma is $2.68.

  • What is the current market cap of Sunshine Biopharma?

    The current market capitalization of Sunshine Biopharma is $5.36M.

  • What is Sunshine Biopharma’s current revenue?

    The trailing twelve month revenue for Sunshine Biopharma is $33M.

  • Who are Sunshine Biopharma’s competitors?

    Ionis Pharmaceuticals, Kintara Therapeutics, Gilead Sciences, Amgen, and Merck & Co. are some of the 9 competitors of Sunshine Biopharma.

  • What is Sunshine Biopharma’s annual earnings per share (EPS)?

    Sunshine Biopharma’s EPS for 12 months was -$127.90.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »